Apple could turn the AirPods into an FDA-approved hearing aid in the future, or have the device become another product that watches over users' health.
"Power On," Bloomberg writer Mark Gurman's weekly tech newsletter, is disseminated every Sunday and today was no exception. One of the interesting topics that Gurman mentioned in the latest version of"Power On" is how Apple plans on turning the AirPods, its wireless Bluetooth earbuds, into a"health tool" over the next year or two.
Gurman writes that he wouldn't be surprised if Apple eventually makes the AirPods an FDA-approved hearing aid. Recently, the rules were changed in the U.S. and hearing aids can now be purchased without a prescription and this would allow to market future AirPods as a hearing aid. Gurman says that offering AirPods as hearing aids could possibly help more than tens of millions of people.Back in 2016, Apple received a patent for a system that would allow Apple to track a user's heart rate, body temperature, and other health-related biometric data. The biometric sensor would be placed inside one of the earbuds.
Besides the aforementioned Live Listen feature, there is an option for AirPods Pro users who are hard of hearing. Conversation Boost, when enabled, uses the microphone on the device to help amplify conversations taking place right in front of the user. It's not as helpful or as powerful as Live Listen, but it does make it a little easier for the user to follow a conversation.
With the Apple Watch already well known for using its health-related features to save lives, it's possible that Apple sees the possibility of marketing the two wearable devices as one health-related tool and offers some kind of bundle.
Deutschland Neuesten Nachrichten, Deutschland Schlagzeilen
Similar News:Sie können auch ähnliche Nachrichten wie diese lesen, die wir aus anderen Nachrichtenquellen gesammelt haben.
Pfizer migraine nasal spray snags FDA approval for summer launchNews of the FDA’s approval came after two randomized, double-blind, placebo-controlled studies.
Weiterlesen »
FDA approves nasal spray to treat migrainesZavzpret is the first nasal spray approved to block calcitonin gene-related peptide, a protein believed to contribute to migraines.
Weiterlesen »
U.S. FDA approves Acadia's genetic Rett syndrome drugThe U.S. Food and Drug Administration approved Acadia Pharmaceuticals Inc's drug for the treatment of Rett syndrome, a genetic brain disorder, the company said on Friday, making it the first approved drug for the condition.
Weiterlesen »
Migraine nasal spray from Pfizer snags FDA approval for expected summer launchThe FDA has approved Pfizer's nasal spray to treat migraines in adults. The medication, called Zavzpret, is expected to be available via a doctor's prescription in July 2023.
Weiterlesen »
Pfizer says the FDA has approved its migraine nasal spray ZavzpretDrugmaker plans to roll out the drug, which it says can relieve migraine symptoms in 30 minutes, to pharmacies in July.
Weiterlesen »
The FDA Now Says Eating Some Chocolate May Reduce Your Heart Disease RiskFollowing a four-year review, the FDA has finally responded to a petition for a health claim on the link between chocolate and heart disease.
Weiterlesen »